Terms: = Prostate cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
8 results:
1. Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis.
Wang X; Wu Y; Liu J; Xu X; Sheng Z; Liu W; Chen M; Ma Y; Zhao D; Li D; Zheng X
Toxicol Appl Pharmacol; 2022 Oct; 452():116169. PubMed ID: 35926565
[TBL] [Abstract] [Full Text] [Related]
2. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for pai-1.
Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
[TBL] [Abstract] [Full Text] [Related]
3. ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.
Pellinen T; Blom S; Sánchez S; Välimäki K; Mpindi JP; Azegrouz H; Strippoli R; Nieto R; Vitón M; Palacios I; Turkki R; Wang Y; Sánchez-Alvarez M; Nordling S; Bützow A; Mirtti T; Rannikko A; Montoya MC; Kallioniemi O; Del Pozo MA
Sci Rep; 2018 Feb; 8(1):2338. PubMed ID: 29402961
[TBL] [Abstract] [Full Text] [Related]
4. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
Guo K; Zheng S; Xu Y; Xu A; Chen B; Wen Y
Tumour Biol; 2016 Sep; 37(9):12843-12854. PubMed ID: 27449037
[TBL] [Abstract] [Full Text] [Related]
5. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract] [Full Text] [Related]
6. [Tumor-associated prognostic factors of the plasminogen activator family: determination and clinical value of u-PA, t-PA, pai-1, and pai-2].
Mengele K; Harbeck N; Reuning U; Magdolen V; Schmitt M
Hamostaseologie; 2005 Aug; 25(3):301-10. PubMed ID: 16113755
[TBL] [Abstract] [Full Text] [Related]
7. Transforming growth factor beta1 stimulates urokinase plasminogen activator system on prostate cancer cells.
Unlü A; Leake RE
Int J Biol Markers; 2003; 18(2):147-51. PubMed ID: 12841684
[TBL] [Abstract] [Full Text] [Related]
8. The fibrinolytic system in neoplasia.
Bell WR
Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
[TBL] [Abstract] [Full Text] [Related]
